Interestingly, comparable longevity of ATG4B‐deficient AML model mice was observed after serial transplantation, suggesting a lower rate of malignant evolution in ATG4B‐deficient AML cells (Figure 7E,H,K). Here, ATG4B is linked to acute myeloid leukemia.